SAN DIEGO--(BUSINESS WIRE)--Growing direct-selling conglomerate Youngevity® Essential Life Sciences (www.Youngevity.com) announces it has signed an agreement to initiate a series of clinical research studies at Clemson University’s Institute of Nutraceutical Research. Formally titled “Research Studies on Anti-Cancer and Anti-Inflammatory Efficacy and Safety of Youngevity Nutraceutical Products,” the research will be overseen by Professor Chittaranjan Kole, Director of Research at the Institute, who is a specialist in plant genomics, phytomedicine and nutriomics. Youngevity Essential Life Sciences is a wholly owned subsidiary of AL International (PINKSHEETS: JCOF) (www.alintjcof.com), a global marketer of lifestyle and nutritional products and services and gourmet coffee.
The placebo-controlled, validation research studies will not be tested in humans, however will be testing specific human biomarkers, including inflammation, bacterial, and disease management. Products featured in Youngevity’s “90 for Life” campaign, including its signature “90 Essential Nutrients” blend, will be used primarily in these early studies. The research will build on work performed by Youngevity cofounder Dr. Joel Wallach over the course of 30 years. The Clemson University studies will begin immediately and will conclude by the end of 2012. Youngevity expects to continue to work with a variety of academic and private organizations to further study the potential effects of its products on various health markers.
“We are excited to work with Youngevity,” said Dr. Kole. “Research such as the studies that Youngevity is performing further the intent of this Institute and the entire field of Nutraceuticals. This is a very exciting time for all of us.”
Clemson University serves as one of the leading research universities in the U.S. The mission of the Institute of Nutraceutical Research is to make Clemson the national leader in nutritional research. Its goals are to develop greater confidence in product quality, and effectiveness, and to enhance consumer demand for quality nutraceutical products. The Institute is one of the most highly regarded organizations in the field of phytonutrients, vitamins and minerals.
Steve Wallach, CEO of Youngevity, said, “We are looking forward to working with Dr. Kole at Clemson University to perform these clinical research studies, which will allow us to study potential links between our products and various biomarkers. Among the top universities and academic facilities we considered, Clemson had the greatest expertise in this area, and they are consistently innovating in the areas of nutrition and nutraceuticals.”
Dr. Joel Wallach, cofounder of Youngevity, said, “Youngevity products have always been deeply rooted in solid science. As a physician and medical researcher, I always used this as my ultimate guide in formulation and development of new products. Ongoing research with respected and reputable academic institutions such as Clemson extends our commitment to provide the best products to our distributors and customers.”
About Youngevity® Essential Life Sciences
Youngevity Essential Life Sciences (www.Youngevity.com), headquartered in San Diego, CA, is a nutrition and lifestyle-related services company dedicated to promoting vibrant health and flourishing economics. Founded in 1997 by Drs. Joel Wallach, DVM, ND, and Ma Lan, MD, as AL Global, Inc., the company adopted the name Youngevity in 2006. Youngevity is the only network marketing company to have a qualified FDA Health Claim. Dr. Wallach’s work has been published in more than 70 peer-reviewed and referenced scientific journals and books.
About AL International
AL International, Inc. (JCOF.PK) (www.alintjcof.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a “network of networks.” The company also is a vertically integrated producer of the finest coffees for the commercial, retail and direct sales channels. AL International was formed after the merger of Youngevity Essential Life Sciences (www.youngevity.com) and Javalution Coffee Company in the summer of 2011.
Safe Harbor Statement
This release includes forward-looking statements on our current expectations and projections about future events. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates” and similar expressions. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict and include statements relating to our business plan and growth strategy through acquisition. The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from those reflected in our forward-looking statements include, among others, the ability to implement our business plan and growth strategy through acquisition and the continued growth of our distributor base. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.